Ondine Biomedical Inc. (LON:OBI – Get Free Report) shares traded up 1.5% during mid-day trading on Friday . The stock traded as high as GBX 8.25 ($0.10) and last traded at GBX 8.25 ($0.10). 29,881 shares changed hands during mid-day trading, a decline of 91% from the average session volume of 331,950 shares. The stock had previously closed at GBX 8.13 ($0.10).
Ondine Biomedical Price Performance
The firm has a market capitalization of £22.88 million, a P/E ratio of -275.00 and a beta of 0.10. The business’s fifty day moving average is GBX 7.23 and its 200 day moving average is GBX 7.45. The company has a current ratio of 0.80, a quick ratio of 8.26 and a debt-to-equity ratio of 1,847.37.
Ondine Biomedical Company Profile
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
Featured Articles
- Five stocks we like better than Ondine Biomedical
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Disney’s Magic Strategy: Reinventing the House of Mouse
- Which Wall Street Analysts are the Most Accurate?
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- What is a support level?
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
